EUXS:LSE:LSE-iShares MSCI Europe Ex UK GBP (GBX)

ETF | Others |

Last Closing

USD 727.2

Change

+8.40 (+1.17)%

Market Cap

USD 0.16B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-5.45 (-3.05%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.25 (+1.40%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.16 (+1.16%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

-3.52 (-3.36%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.20 (+0.28%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.40 (+1.33%)

USD 259.48B
0QZO:LSE 0QZO

+0.80 (+0.95%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-1.00 (-0.73%)

USD 202.26B
0R24:LSE Intel Corp.

-0.76 (-3.91%)

USD 196.14B

ETFs Containing EUXS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.12% 72% C 69% C-
Dividend Return 0.00% 3% F 1% F
Total Return 1.12% 71% C- 68% D+
Trailing 12 Months  
Capital Gain 1.58% 47% F 54% F
Dividend Return 0.02% 17% F 14% F
Total Return 1.60% 42% F 51% F
Trailing 5 Years  
Capital Gain 63.07% 60% D- 67% D+
Dividend Return 0.15% 18% F 25% F
Total Return 63.21% 56% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 9.93% 63% D 67% D+
Dividend Return 9.97% 62% D 66% D+
Total Return 0.04% 31% F 24% F
Risk Return Profile  
Volatility (Standard Deviation) 13.25% 52% F 70% C-
Risk Adjusted Return 75.26% 73% C 83% B
Market Capitalization 0.16B 56% F 32% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.